Samuel Amintas
-
- Cancer Genomics and Diagnostics 4
-
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Screening and Detection 2
-
- CRISPR and Genetic Engineering 6
- Advanced biosensing and bioanalysis techniques 3
- Single-cell and spatial transcriptomics 2
-
- Sirtuins and Resveratrol in Medicine 3
-
- Renal cell carcinoma treatment 2
- Co-authors
- Sandrine DabernatAurélie BedelFrançois Moreau‐GaudryJulian BoutinThierry LevadeJeffrey A. MedinV. VendrelyJean‐Philippe Merlio
- Partner nations
- FranceSwitzerlandCanada
In The Last Decade
Samuel Amintas
24 papers receiving 431 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 88
- Oncology 122
- Business and International Management 8
- Molecular Biology 275
- Genetics 34
Countries citing papers authored by Samuel Amintas
This map shows the geographic impact of Samuel Amintas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Amintas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Amintas more than expected).
Fields of papers citing papers by Samuel Amintas
This network shows the impact of papers produced by Samuel Amintas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Amintas. The network helps show where Samuel Amintas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Samuel Amintas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 16 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 29 | |
| 14 | 2022 | 24 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 2 | |
| 17 | 2021 | 31 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 4 | |
| 20 | 2019 | 34 |
About Samuel Amintas
Samuel Amintas is a scholar working on Geriatrics and Gerontology, Business and International Management and Molecular Medicine, having authored 27 papers that have together received 441 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (6 papers), Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Single-cell and spatial transcriptomics (2 papers), Renal cell carcinoma treatment (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Cancer Research (88 citations), Oncology (122 citations) and Business and International Management (8 citations). Samuel Amintas has collaborated with scholars based in France, Switzerland and Canada. Frequent co-authors include Sandrine Dabernat, Aurélie Bedel, François Moreau‐Gaudry, Julian Boutin, Thierry Levade, Jeffrey A. Medin, V. Vendrely, Jean‐Philippe Merlio, Étienne Buscail and Louis Buscail.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.